Decreased serotonin transporter binding in unaffected relatives of manic depressive patients.

Article Details

Citation

Copy to clipboard

Leboyer M, Quintin P, Manivet P, Varoquaux O, Allilaire JF, Launay JM

Decreased serotonin transporter binding in unaffected relatives of manic depressive patients.

Biol Psychiatry. 1999 Dec 15;46(12):1703-6.

PubMed ID

10624553 [ View in PubMed

]

Abstract

BACKGROUND: There are numerous reports of decreased binding to platelet serotonin transporter (5-HTT) in depression, suggesting that it might be considered a trait marker of depression. To further investigate whether reduced 5-HTT function could be an endophenotype in manic depressive illness, we looked for abnormalities of platelet 5-HTT among subjects who are potential carriers of genetic vulnerability to manic depressive illness (MDI). METHODS: Blood samples were obtained from 20 unaffected relatives from families with at least two individuals with bipolar disorder and from 19 control participants. Plasma 5-HIAA, platelet 5-HT, and [3H] imipramine binding were measured. RESULTS: Unaffected relatives manifested lower platelet 5-HTT function than control participants as revealed both by reduced number and diminished affinity of imipramine binding sites and diminished platelet 5-HT content. CONCLUSIONS: These preliminary results suggest that reduced 5-HTT function could be considered a trait marker or an endophenotype in MDI.

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Imipramine	Sodium-dependent serotonin transporter	Protein	Humans	Yes	Inhibitor	Details